RT-qPCR and western blotting were then performed to examine CDKN2AIP levels in HCC cells with NR4A3 overexpression or knockdown (Fig. 5B-C and Fig. S4B-S4G). This evidence concerns the gene CDKN2AIP and hepatocellular carcinoma.